Optiscan Imaging Ltd
  • Home
  • About Us
    • Who We Are
    • Our Purpose and Values
    • Board
    • Partners
    • Distributors
    • Compliance
    • Careers
  • Technology
    • Our Solution
    • Technology Introduction
    • Platform Technology
    • Publications
    • Image Gallery
    • Webinars
    • FAQ
  • Products
    • Our Products
    • InVivage
    • ViewnVivo
    • Customisation
  • Pipeline
  • Investor
    • Investor Overview
    • ASX Announcements
    • Reports
    • Share Price Information
    • Financial Calendar
    • Media Coverage
    • Sustainability
    • Share Registry
    • Investor Alerts
  • Media
    • News
    • Social Media Feed
    • Blog / Newsletter
  • Contact
    • Contact

Sub-heading can be edited through HQI

Home > Media > News
    • News
    • Social Media Feed
    • Blog / Newsletter

Recent Posts

  • Optiscan Imaging Featured in Australian Financial Review
  • Dr. Camile Farah talks with Matt Birney on 2GB Sydney Radio
  • Optiscan Launches World Cancer Day 2023 Awareness Initiative
  • Dr. Camile Farah talks with Matt Birney on 6PR Perth Radio
  • Dr. Camile Farah talks with Matt Birney on 3AW 693 Melbourne Radio

Archives

  • March 2023
  • February 2023
  • January 2023
  • November 2022
  • September 2022
  • February 2022
  • May 2021
  • March 2021
  • January 2021
  • December 2020

Categories

  • Announcements
  • Blood vessel, perfusion, and barrier function
  • Brain cancer
  • Broker Research
  • Cell viability
  • Cervical assessment
  • Gastrointestinal assessment
  • General surgery
  • Intraoperative surgery and tumour margin delineation
  • Live antibody labelling
  • Live microflora imaging
  • Nano particle and drug delivery
  • Optiscan news
  • Oral cancer diagnosis and surgical margin
  • Proof of concept in live models
  • Uncategorized

Optiscan Imaging and Prolucid Featured in The Market Herald

Posted on January 31st, 2023. by Andrew Barker

Market Herald Update

We would like to advise our recent ASX announcement detailing our partnership with Prolucid Technologies to develop AI algorithms and clinical workflows, has received coverage in The Market Herald.

Read the article and news report here

Posted in Optiscan news

Select Category

  • Optiscan news
  • Partner news
  • Media

Quick Links

Contact Us

Optiscan Imaging Ltd
16 Miles Street, Mulgrave
Melbourne VIC 3170
AUSTRALIA

T: +61 (3) 9538 3333
E: info@optiscan.com

Optiscan Imaging Ltd
16 Miles Street, Mulgrave
Melbourne VIC 3170
AUSTRALIA

T: +61 (3) 9538 3333
E: info@optiscan.com

Stay Connected

Register Your Interest

Subscribe to Investor Alerts

Stay in Touch

Which of the following group do you best fit?

 

Email Alerts

Subscribe to Email Alerts

Follow Us

Copyright © Optiscan Imaging Ltd
Site Map Search Terms of Use Privacy Policy Cookies Policy
Site by